Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Current Leases (2019 - 2025)

International Stem Cell (ISCO) has disclosed Current Leases for 7 consecutive years, with $383000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Current Leases rose 21.59% to $383000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $383000.0, a 21.59% increase, with the full-year FY2024 number at $330000.0, up 19.57% from a year prior.
  • Current Leases was $383000.0 for Q3 2025 at International Stem Cell, up from $371000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $383000.0 in Q3 2025 to a low of $179000.0 in Q4 2021.
  • A 5-year average of $281210.5 and a median of $288000.0 in 2024 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: tumbled 48.27% in 2021, then grew 28.49% in 2022.
  • International Stem Cell's Current Leases stood at $179000.0 in 2021, then grew by 28.49% to $230000.0 in 2022, then rose by 20.0% to $276000.0 in 2023, then increased by 19.57% to $330000.0 in 2024, then rose by 16.06% to $383000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Current Leases are $383000.0 (Q3 2025), $371000.0 (Q2 2025), and $361000.0 (Q1 2025).